Sutro Biopharma

$21.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.29 (-5.60%) Today
$0.00 (0.00%) As of 12:32 PM UTC after-hours

Why Robinhood?

You can buy or sell STRO and other stocks, options, and ETFs commission-free!

About STRO

Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. It focuses on next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA. The listed name for STRO is Sutro Biopharma, Inc. Common Stock.

CEO
William J. Newell
Employees
168
Headquarters
South San Francisco, California
Founded
2003
Market Cap
935.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
398.62K
High Today
$23.90
Low Today
$21.52
Open Price
$22.98
Volume
299.62K
52 Week High
$28.30
52 Week Low
$6.00

STRO Earnings

-$0.84
-$0.41
$0.02
$0.45
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market

You May Also Like

KALL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure